The Indian Cancer Genetics and Genomics Conference-2020
The Indian Cancer Genetics and Genomics Conference-2020 (ICGGC-2020) was organized on a hybrid-virtual platform on the 24th and 25th of November 2020. This was organised by the Department of Medical Oncology, AIIMS, New Delhi in association with the Indo-UK Genetic Education Forum, under the aegis of the Research and Education Society of medical Oncology (RESMO).
Genetics and genomics are playing an ever-increasing role in deciding the management of cancers, be it the diagnosis, prognosis, precision therapeutic management or precision prevention. The role of genomics and genetics in oncology is evolving at an extremely fast pace and it is prudent to keep abreast of it. Precision prevention, particularly identifying the high-risk families and unaffected relatives has a tremendous potential for preventing cancers and altering the natural history of the disease. With this intent in mind, this conference was planned to present the current state-of -the art management in Clinical Cancer Genetics. It was an educational event targeted to the residents training in medical, surgical, radiation oncology and gynaecological and breast surgery in different institutes all over the country.
The conference had a galaxy of esteemed faculty, including renowned clinicians and geneticists from the United kingdom, the United Sates, leading academic institutes across the length and breadth of India including AIIMS-New Delhi, Tata Memorial Hospital-Mumbai, PGIMER-Chandigarh, JIPMER-Puducherry, Cancer Institute-Adyar, Chennai.
The first day was dedicated to Hereditary breast and ovarian cancers and the speakers explained the current concepts and the state- of – the art practice. Important data from European and Indian studies were presented and discussed. Panel discussion explaining the important aspects of clinical management was organised. The second day was dedicated was Lynch syndrome, Li Fraumeni, Retinoblastoma and other miscellaneous cancers. The laboratory principles, technical details of reporting, genetic counselling etc were addressed.
The event was attended online and appreciated by more than 800 viewers all over the world. The videos of the event, both days 1 & 2 are available at the link on the institute website.
Name: Dr. Deepam Pushpam
Qualification: MD (Internal Medicine), DM (Medical Oncology)
Designation: Assistant Professor, Department of Medical Oncology.
Address: Room No. 245, Department of Medical Oncology 2nd Floor, Dr B.R.A-I.R.C.H, AIIMS , Ansari Nagar, New Delhi 110029.
Contact info: Email: यह ईमेल पता spambots से संरक्षित किया जा रहा है. आप जावास्क्रिप्ट यह देखने के सक्षम होना चाहिए.
Academic career: Dr. Deepam Pushpam graduated from the Guwahati Medical College, Guwahati University and received his MD degree in Internal Medicine from AIIMS, Delhi. He did his senior resident ship in Medical oncology at the Dr. B. R. A- IRCH, AIIMS, New Delhi and completed his DM degree in Medical Oncology from AIIIMS. He was recruited as a faculty in Medical Oncology at the Dr. B R A –IRCH, AIIMS, New Delhi in 2018.
Area of Expertise: Dr. Deepam Pushpam is a member of the multidisciplinary teams at Dr. B.R.A-IRCH taking care of pediatric solid cancer, soft tissue sarcoma, melanoma, pediatric and adult hematological malignancies and hematopoietic stem cell transplant. He routinely takes care of these patients in the OPD and wards. He has keen interest in hematopoietic stem cell transplant for congenital disorders in children, cord blood transplant, allogeneic hematopoietic stem cell transplant and haploidentical stem cell transplant. He also actively participates in clinical services for lung cancer.
Research interest: Acute lymphoblastic leukemia, chronic myeloid leukemia, rare pediatric tumors, and soft tissue sarcoma.
Membership of Professional bodies:
1. Member: European Society for Medical Oncology, (ESMO).
2. Member: Indian Society of Medical and Paediatric Oncology,(ISMPO)
3. Member: Paediatric Hemato-Oncology chapter of Inadian Academy of Paediatrics (PHO-IAP)
|S.NO||NAMES||MONTH AND YEAR OF PASSING||PHOTO|
|1||DR. GOTTEMUKKALA MURALIK RAJU||Feb-99|
|2||DR. ASHUTOSH PATHAK||May-02|
|3||DR. PRATIBHA SHARMA||Jan-10|
|4||DR. RASHMI BHARDWAJ||Sep-10|
|5||DR. RAKESH VERMA||Mar-11|
|6||DR. NITIN MATHUR||Feb-12|
|7||DR. SURENDER KUMAR SHARAWAT||May-13|
|9||Dr. Minakshi Mann||
February 2014 – July 2020
Dr. Anudishi Tyagi
|January 2013 - February 2019|
|11||Dr. Shivali Jasrotia||August 2011 - July 2019|
Dr. Mohsin Maqbool
February 2010 - December 2018
Name: ATUL BATRA
Date of birth: 02-01-1986
Designation: Assistant Professor, Department of Medical Oncolocgy
Contact details: यह ईमेल पता spambots से संरक्षित किया जा रहा है. आप जावास्क्रिप्ट यह देखने के सक्षम होना चाहिए. / यह ईमेल पता spambots से संरक्षित किया जा रहा है. आप जावास्क्रिप्ट यह देखने के सक्षम होना चाहिए. ;
Links for your research blogs:
MBBS Maulana Azad Medical College, Delhi 2008
MD (Medicine) AIIMS , New Delhi 2011
DNB (Medical Oncology) NBE 2017
MRCP (SCE-Medical Oncology) RCP 2017
ECMO ESMO 2015
Senior Resident (Academic) AIIMS, New Delhi January 2013-2015
Senior Resident (Medical Oncology) AIIMS, New Delhi January 2016-November 2016
Assistant Professor (Medical Oncology) AIIMS, New Delhi November 2016 - Present
MAJOR CLINICAL INTERESTS
Dr.Batra is a member of the multidisciplinary teams at Dr. B.R.A-IRCH taking care of Breast cancer, and Genitourinary cancers and routinely takes care of these patients in the OPD and wards. He also actively participates in clinical services for adult haematological malignancies e.g. Hodgkins lymphoma, NHL, Acute and Chronic Leukemias and Multiple myeloma.
MAJOR RESEARCH INTERESTS
1. Breast Cancer
2. Prostate Cancer
3. Renal Cell Cancer
4. Urinary Bladder Cancer
5. Germ Cell Tumor
1. Pramanik R, Agarwala S, Gupta YK, Thulkar S, Vishnubhatla S, Batra A, Dhawan D, Bakhshi S. Metronomic Chemotherapy vs Best Supportive Care in Progressive Pediatric Solid Malignant Tumors : A Randomized Clinical Trial. JAMA Oncol. 2017 Sep 1;3(9):1222-1227. doi: 10.1001/jamaoncol.2017.0324.
2. Biwas, B. Rastogi, S. Batra, A. Trastuzumab and Lapatinib in HER2-positive Metastatic Colorectal Cancer. Natl Med J India. 2016 Jul-Aug;29(4):219-220.
3. Srivastava R, Batra A, Dhawan D, Bakhshi S. Association of energy intake and expenditure with obesity: A cross-sectional study of 150 pediatric patients following treatment for leukemia. Pediatr Hematol Oncol. 2017 Feb;34(1):29-35. doi: 10.1080/08880018.2016.
4. Batra A, Kashyap S, Singh L, Bakhshi S. Expression of Sirtuin1 in Retinoblastoma and its correlation with histopathological features. Ocul Oncol Pathol. 2015 Dec;2(2):86-90. doi: 10.1159/000439594.
5. Batra A, Kain R, Kumari M, Paul R, Dhawan D, Bakhshi S. Parents' Perspective of Quality of Life of Retinoblastoma Survivors. Pediatr Blood Cancer. 2016 Jul;63(7):1287-9. doi: 10.1002/pbc.25982.
6. Batra A, Bakhshi S.The safety and efficacy of aprepitant in combination with other antiemetic agents for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in pediatric patients. Expert Review of Quality of Life in Cancer Care Vol. 1 , Iss. 3,2016. doi: 10.1080/23809000.2016.1174069.
7. Dabas A, Batra A, Khadgawat R, Jyotsna VP, Bakhshi S. Growth and Endocrinal Abnormalities in Pediatric Langerhans Cell Histiocytosis. Indian J Pediatr. 2016 Jul;83(7):657-60. doi: 10.1007/s12098-016-2053-y.
8. Batra A, Pushker N, Venkatesh P, Arora T, Tewari R, Bakhshi S. Long-term visual outcomes in retinoblastoma survivors. Clin Transl Oncol. 2016 Oct;18(10):1034-8. doi: 10.1007/s12094-016-1482-4.
9. Srivastava R, Batra A, Tyagi A, Dhawan D, Ramakrishnan L, Bakhshi S. Adiponectin correlates with obesity: A study of 159 childhood acute leukemia survivors from India.Indian J Cancer. 2015 Apr-Jun;52(2):195-7. doi: 10.4103/0019-509X.175824.
10. Batra A, Kumari M, Paul R, Patekar M, Dhawan D, , Bakhshi S, Quality of life in retinoblastoma: A cross-sectional study from India. Pediatr Blood Cancer. 2016 Feb;63(2):313-7. doi: 10.1002/pbc.25781.
11. Nataraj V, Batra A, Rastogi S, Khan SA, Sharma MC, Vishnubhatla S, Bakhshi S. Developing a prognostic model for patients with localized osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate: A single-center experience of 237 patients. J Surg Oncol. 2015 Nov;112(6):662-8. doi: 10.1002/jso.24045.
12. Batra A, Bakhshi S. Aprepitant for paediatric chemotherapy-induced nausea and vomiting. Lancet Oncol. 2015 Jun;16(6):e259-60. doi: 10.1016/S1470-2045(15)70244-5.
13. Batra A, Kashyap S, Singh L, Bakhshi S. Expression of FOXO3a in Retinoblastoma and its correlation with histopathological features. Appl Immunohistochem Mol Morphol. 2017 Feb;25(2):95-99. doi: 10.1097/PAI.0000000000000278.
14. Batra A, Patekar M, Bakhshi S. Short stature in Retinoblastoma. Clin Transl Oncol.2016 Apr;18(4):381-4. doi: 10.1007/s12094-015-1380-1.
15. Batra A, Thakar A, Bakhshi S. Ototoxicity in retinoblastoma survivors treated with carboplatin based chemotherapy: A cross-sectional study of 116 patients. Pediatr Blood Cancer. 2015 Nov;62(11):2060. doi: 10.1002/pbc.25618.
16. Bakhshi S, Batra A, Biswas B, Dhawan D, Paul R, Sreenivas V. Aprepitant as an Add-on Therapy in Children Receiving Highly Emetogenic Chemotherapy: A Randomized, DoubleBlind, Placebo-Controlled Trial. Support Care Cancer. 2015 Nov;23(11):3229-37. doi: 10.1007/s00520-015-2714-9.
17. Kumar L, Iqbal N, Mookerjee A, Verma RK, Sharma OD, Batra A, Pramanik R, Gupta R.Complete response after autologous stem cell transplant in multiple myeloma.Cancer Med. 2014 Aug;3(4):939-46. doi: 10.1002/cam4.257.
18. Soneja M, Batra A, Vikram NK, Ahuja A, Mohan A, Sood R. Actinomycosis and nocardiosis co-infection in chronic granulomatous disease. J Assoc Physicians India. 2012 Apr;60:66-8.
19. Singh N, Tripathi R, Tyagi S, Batra A. Antepartum fetal bladder rupture leading to urinary ascitis:attempt to rescue by placement of peritoneo-amniotic shunt. BMJ Case Rep. 2013 Aug 13;2013. pii: bcr2013200021. doi: 10.1136/bcr-2013-200021.
20. Singh N, Tripathi R, Mala YM, Dixit R, Batra A. Comparison of scar thickness measurements by Trans Vaginal Sonography and Magnetic Resonance Imaging in cases of pregnancy with previousCaesarean section. Do they correlate with actual scar thickness? Journal of Obstetrics & Gynaecology 2013 Nov;33(8):810-3.doi: 10.3109/01443615.2013.823.926.
21. Singh N, tripathi R, Mala YM, Batra A. Diagnostic dilemma in corneal pregnancy-3DUltrasonography may Aid!!; J Clin Diagn Res. 2015 Jan;9(1):QD12-3. doi: 10.7860/JCDR/2015/6775.5484.
ABSTRACTS IN INDEXED JOURNALS:
American Society of Clinical Oncology (ASCO)
European Society of Medical Oncology (ESMO)
International Society of Pediatric Oncology (SIOP)
Young Investigator Group of SIOP(YI-SIOP)
Indian Society of Medical and Pediatric Oncology (ISMPO)
Dr Lalit Kumar, MD; DM
Professor and Head
Department of Medical Oncology
All India Institute of Medical sciences
(Dr BRA Institute Rotary Cancer Hospital)
New Delhi 110029, India
E-Mail: medoncoaiims यह ईमेल पता spambots से संरक्षित किया जा रहा है. आप जावास्क्रिप्ट यह देखने के सक्षम होना चाहिए.